Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Emerald Bioventures, LLC — Galera Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Emerald Bioventures, LLC

Emerald Bioventures, LLC

10% owner at Galera Therapeutics, Inc. · on record since May 4, 2026

Insider trading activity of Emerald Bioventures, LLC

Transactions on record: 2; since May 29, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 29, 2026

Figures computed from official regulatory filings — methodology.

Companies where Emerald Bioventures, LLC has traded

Galera Therapeutics, Inc.2 tx · May 29, 2026

Track record of Emerald Bioventures, LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Emerald Bioventures, LLC

Co-insiders of Emerald Bioventures, LLC

Alleva Lawrence MGalera Therapeutics, Inc.
ALPHA PHARMA Investments LLCGalera Therapeutics, Inc.
Altamont Pharmaceutical Holdings, LLCGalera Therapeutics, Inc.
Bachleda MarkGalera Therapeutics, Inc.
BARRIS PETER JGalera Therapeutics, Inc.
BASKETT FORESTGalera Therapeutics, Inc.
Beardsley Robert AGalera Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Blackstone Clarus GP L.L.C.Galera Therapeutics, Inc.

Blackstone Clarus GP L.P.Galera Therapeutics, Inc.

Blackstone Group L.P.Galera Therapeutics, Inc.

Blackstone Group Management L.L.C.Galera Therapeutics, Inc.

Blackstone Holdings I/II GP IncGalera Therapeutics, Inc.

Blackstone Holdings II L.P.Galera Therapeutics, Inc.

Brill JeffreyGalera Therapeutics, Inc.

Buckler Regina A.Galera Therapeutics, Inc.

CHANG NANCY TGalera Therapeutics, Inc.

Clarus IV-A, L.P.Galera Therapeutics, Inc.

Clarus IV-B, L.P.Galera Therapeutics, Inc.

Clarus IV-C, L.P.Galera Therapeutics, Inc.

Clarus IV-D, L.P.Galera Therapeutics, Inc.

Clarus IV GP L.P.Galera Therapeutics, Inc.

Cunningham EmmettGalera Therapeutics, Inc.

Degnan ChrisGalera Therapeutics, Inc.

Florence Anthony A. Jr.Galera Therapeutics, Inc.

Fratamico ArthurGalera Therapeutics, Inc.

FRIEDMAN MICHAEL R.Galera Therapeutics, Inc.

Fuller JasonGalera Therapeutics, Inc.

HEALY JAMESGalera Therapeutics, Inc.

HOLMLUND JON TGalera Therapeutics, Inc.

Keene JeffreyGalera Therapeutics, Inc.

Kennedy Eugene P.Galera Therapeutics, Inc.

KERINS PATRICK JGalera Therapeutics, Inc.

LOKAY KEVIN GGalera Therapeutics, Inc.

Matthes Catherine L.Galera Therapeutics, Inc.

Mehra AnandGalera Therapeutics, Inc.

MOTT DAVID MGalera Therapeutics, Inc.

NEA 14 GP, LTDGalera Therapeutics, Inc.

NEA Partners 14, L.P.Galera Therapeutics, Inc.

New Enterprise Associates 14, L.P.Galera Therapeutics, Inc.

NOVARTIS AGGalera Therapeutics, Inc.

Novartis Bioventures LtdGalera Therapeutics, Inc.

Novo A/SGalera Therapeutics, Inc.

Opler TimothyGalera Therapeutics, Inc.

Pearson Mark E.Galera Therapeutics, Inc.

POWELL MICHAELGalera Therapeutics, Inc.

Riley DennisGalera Therapeutics, Inc.

Ross Stephen AGalera Therapeutics, Inc.

SANDELL SCOTT DGalera Therapeutics, Inc.

Schall OttoGalera Therapeutics, Inc.

Schneid YairGalera Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Galera Therapeutics, Inc.	May 29, 2026	Other	20,813,818	—	—	SEC
Galera Therapeutics, Inc.	May 29, 2026	OtherD	-20,813.82	—	—	SEC